(Q34504839)

2 August 2017

1 reference

title

The medicalization of menopause: critique and consequences (English)

1 reference

2 August 2017

V F Meyer

1

1 reference

2 August 2017

publication date

1 January 2001

1 reference

International Journal of Health Services

2 August 2017

published in

1 reference

2 August 2017

volume

31

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

769-792

1 reference

Hormone replacement therapy for all? Universal prescription is desirable

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The social construction of menopause as risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Menopause and hormone replacement therapy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Relationship between serum sex hormones and coronary artery disease in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Coronary heart disease in relation to age, sex, and the menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Myth and paradox of coronary risk and the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The gynecologist and the prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Menopause and the risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Menopause and heart disease. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Cigarette smoking, relative weight, and menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Menopause and risk of cardiovascular disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen and coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Prevalence and determinants of estrogen replacement therapy in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Postmenopausal estrogen and prevention bias

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen replacement therapy: indications, contraindications, and agent selection

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Coronary heart disease in women. Gender differences and effects of menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Postmenopausal hormone therapy. Is it useful for coronary prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Secular trends in the incidence of hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The effect of postmenopausal estrogen therapy on bone density in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Involutional osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Habitual physical activity and bone mineral density in postmenopausal women in England

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Alternative therapies for menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Alzheimer disease. Report of the Council on Scientific Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Epidemiology of dementia in Rochester, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The prevalence of dementia: a quantitative integration of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Effects of age, gender and education on selected neuropsychological tests in an elderly community cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The meaning of cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Sex differences in brain aging: a quantitative magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Postmenopausal hormone therapy and cognitive function in healthy older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

A comparative study of prescribing of hormone replacement therapy in USA and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Long-term blood cholesterol-lowering effects of a dietary fiber supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Primary prevention of coronary heart disease in women through diet and lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Effect of postmenopausal estrogen replacement on circulating androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Androgens and women's health: genetic and epidemiologic aspects of lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The role of androgens in menopausal hormonal replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The decline in U.S. cancer mortality from 1991 to 1995: what's behind the numbers?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

American Cancer Society: the world's wealthiest "nonprofit" institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Migration patterns and breast cancer risk in Asian-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The widening gap in death rates among income groups in the United States from 1967 to 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The associations between health and domestic violence in older women: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Somatic consequences of violence against women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Medicalization of menopause and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The marketing of estrogens for menopausal and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The menopause and the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

MSJAMA: gifts to physicians in the consumer marketing era.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

Is Academic Medicine for Sale?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FM77D-YV2Y-D5NU-FXNW

10.2190/M77D-YV2Y-D5NU-FXNW

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference